Literature DB >> 25515001

Normal weight individuals who develop type 2 diabetes: the personal fat threshold.

Roy Taylor1, Rury R Holman2.   

Abstract

Type 2 diabetes (T2DM) is frequently regarded as a disease of obesity and its occurrence in individuals of normal body mass index (BMI) is often regarded as indicating a non-obesity-related subtype. However, the evidence for such a distinct, common subtype is lacking. The United Kingdom Prospective Diabetes Study (UKPDS) cohort of people diagnosed with T2DM in the 1970s and 1980s had a median BMI of only 28 kg/m2. UKPDS data form the basis of current understanding of the condition even though one in three of those studied had a BMI of less than 25 kg/m2. BMI, though, is a population measure and not a rigid personal guide. Weight loss is considered de rigueur for treating obese diabetic individuals, but it is not usually considered for those deemed to have a normal BMI. Given the new evidence that early T2DM can be reversed to normal glucose tolerance by substantial weight loss, it is important to explain why non-overweight people respond to this intervention as well as obese individuals. We hypothesize that each individual has a personal fat threshold (PFT) which, if exceeded, makes likely the development of T2DM. Subsequent weight loss to take the individual below their level of susceptibility should allow return to normal glucose control. Crucially, the hypothesized PFT is independent of BMI. It allows both understanding of development of T2DM in the non-obese and remission of diabetes after substantial weight loss in people who remain obese by definition. To illustrate this concept, we present the distribution curve of BMI at diagnosis for the UKPDS cohort, together with a diagram explaining individual behaviour within the population. The concept of PFT is of practical benefit in explaining the onset of diabetes and its logical management to the non-obese majority of people with T2DM.

Entities:  

Mesh:

Year:  2015        PMID: 25515001     DOI: 10.1042/CS20140553

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  28 in total

Review 1.  What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?

Authors:  D J Cuthbertson; T Steele; J P Wilding; J C Halford; J A Harrold; M Hamer; F Karpe
Journal:  Int J Obes (Lond)       Date:  2017-01-12       Impact factor: 5.095

Review 2.  Calorie restriction for long-term remission of type 2 diabetes.

Authors:  Roy Taylor
Journal:  Clin Med (Lond)       Date:  2019-01       Impact factor: 2.659

3.  Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Akihiro Ohbora; Takao Kojima; Michiaki Fukui
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

4.  Genetic risk scores for body fat distribution attenuate weight loss in women during dietary intervention.

Authors:  M Svendstrup; K H Allin; T I A Sørensen; T H Hansen; N Grarup; T Hansen; H Vestergaard
Journal:  Int J Obes (Lond)       Date:  2017-11-16       Impact factor: 5.095

5.  Role of Neu-p11/luzindole in the regulation of insulin signaling pathways and insulin resistance.

Authors:  Xiuping Li; Shichang Cai; Weidong Yin; Xiaobo Hu; Sujun Zhang; Zhengming Li; Xing Li; Moshe Laudon
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-03-29       Impact factor: 3.848

6.  Adipose tissue: Fat, yet fit.

Authors:  Senthil K Vasan; Fredrik Karpe
Journal:  Nat Rev Endocrinol       Date:  2016-05-27       Impact factor: 43.330

Review 7.  Regulation of immunometabolism in adipose tissue.

Authors:  Manju Kumari; Joerg Heeren; Ludger Scheja
Journal:  Semin Immunopathol       Date:  2017-12-05       Impact factor: 9.623

8.  Type 2 diabetes prevalence in Pakistan: what is driving this? Clues from subgroup analysis of normal weight individuals in diabetes prevalence survey of Pakistan.

Authors:  Azizul Hasan Aamir; Zia Ul-Haq; Sheraz Fazid; Basharat Hussain Shah; Abbas Raza; Ali Jawa; Saeed A Mahar; Ibrar Ahmad; Faisal Masood Qureshi; Adrian H Heald
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-06-19

9.  A Pathophysiology of Type 2 Diabetes Unrelated to Metabolic Syndrome.

Authors:  Marietta Rottenkolber; Christina Gar; Cornelia Then; Lorena Wanger; Vanessa Sacco; Friederike Banning; Anne L Potzel; Stefanie Kern-Matschilles; Claudia Nevinny-Stickel-Hinzpeter; Harald Grallert; Nina Hesse; Jochen Seissler; Andreas Lechner
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

10.  A higher-protein nut-based snack product suppresses glycaemia and decreases glycaemic response to co-ingested carbohydrate in an overweight prediabetic Asian Chinese cohort: the Tū Ora postprandial RCT.

Authors:  Louise W Lu; Marta P Silvestre; Ivana R Sequeira; Lindsay D Plank; Meika Foster; Nikki Middleditch; Alejandra Acevedo-Fani; Kieren G Hollingsworth; Sally D Poppitt
Journal:  J Nutr Sci       Date:  2021-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.